MHRA – Consultation on reclassification of codeine linctus as a prescription only medicine

The CCA submitted its response to MHRA’s consultation on the reclassification of codeine linctus as a prescription-only medicine. This proposal should reduce recreational and/or illegal misuse.

Press Enquiries

For media enquiries, contact [email protected] email us

Back to top of page